Treatment Group 1 (≥30 kg) | Treatment Group 2(15–29 kg) | |||||
---|---|---|---|---|---|---|
D0 | D7 | D28 | D0 | D7 | D28 | |
Hb (mg/L) | ||||||
Male | 11.67 ± 4.12 | 11.15 ± 2.37 | 12.19 ± 2.40 | 10.70 ± 2.65 | 9.53 ± 2.19 | 11.56 ± 1.34 |
Female | 11.47 ± 2.49 | 10.27 ± 1.93 | 11.45 ± 1.42 | 10.84 ± 2.99 | 9.07 ± 3.20 | 11.58 ± 1.35 |
ESR | 23.79 ± 26.74 | 14.34 ± 17.23 | 11.82 ± 14.96 | 42.73 ± 29.16 | 18.17 ± 23.66 | 11.53 ± 13.52 |
TWBC (× 109/L) | 5.27 ± 1.87 | 5.35 ± 1.93 | 5.15 ± 1.54 | 7.25 ± 1.11 | 5.91 ± 2.50 | 5.79 ± 4.85 |
Lymphocytes (× 109/L) | 2.22 ± 1.05 | 2.59 ± 1.09 | 2.66 ± 1.11 | 2.87 ± 3.34 | 2.97 ± 1.69 | 3.14 ± 3.08 |
Neutrophils (× 109/L) | 2.69 ± 1.28 | 2.55 ± 1.10 | 2.33 ± 0.80 | 4.10 ± 8.01 | 2.67 ± 1.21 | 2.47 ± 1.86 |
Monocytes (× 109/L) | 0.24 ± 0.16 | 0.09 ± 0.08 | 0.08 ± 0.08 | 0.09 ± 0.11 | 0.08 ± 0.08 | 0.08 ± 0.96 |
Eosinophils (× 109/L) | 0.12 ± 0.14 | 0.15 ± 0.15 | 0.09 ± 0.11 | 0.08 ± 0.11 | 0.15 ± 0.22 | 0.10 ± 0.11 |